Search

everythinglearnresearchcommunity

for

Search:↓

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Anabolic-androgenic steroids can harm women's health and their offspring.

Autoimmune markers may help diagnose and manage PCOS.

The donkey had a severe disease affecting multiple organs and was euthanized.

STK11 gene polymorphism does not predict metformin response in PCOS.

Postpartum care should address hormonal changes, nutrition, and support to ensure mother and baby well-being.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Zinc is important for skin health, and supplements can help treat various skin and hair disorders, but more research is needed for conditions like psoriasis and vitiligo.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Anabolic-androgenic steroids can damage the brain, causing mood and cognitive problems.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

Endometriosis causes abdominal-pelvic pain, and while surgery and treatments help, pain often persists.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Healthcare providers in Addis Ababa need better education and training for diagnosing PCOS.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Common skin conditions can greatly affect a person's mental health and social life.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

JAK inhibitors show promise for treating various skin diseases.